Novartis has settled a suit by Henrietta Lacks' estate alleging the pharmaceutical giant unjustly profited off cells were ...

Ms. Lacks’s family accused Novartis of profiting from her cells, which were taken from her without her consent in 1951, when ...

It’s the second settlement in lawsuits filed by the estate that accused biomedical businesses of reaping rewards from a ...

The Henrietta Lacks estate has secured a settlement with Novartis over the unauthorized use of her cancer cells, while ...

Novartis, continuing its string of expansions for radioligand therapy manufacturing, announced February 25 that it would ...

Novartis and Genentech are suing a U.S. company and a Canadian pharmacy over the importation of a Canadian version of their ...

Novartis reached a confidential settlement with Henrietta Lacks' family, resolving a second lawsuit over the nonconsensual use of HeLa cells.

The Denton site is part of a network of manufacturing plants Novartis is building across the U.S. to make cancer drugs that must be shipped to patients quickly.

A new biotech has taken flight as a result of Novartis’ red-hot $12 billion acquisition of muscular dystrophy specialist Avidity Biosciences. | A new biotech has risen from the ashes of Novartis’ ...

Novartis ( NVS 0.66%) is a major Swiss drug company with a market capitalization of over $300 billion. Its focus areas are extensive, spanning oncology, immunology, neuroscience, respiratory care, and ...

Outside the drug’s current urticaria niche, Novartis is also developing remibrutinib in myasthenia gravis and multiple ...

CSU affects nearly 4 million people in Europe, with over 50% of patients remaining symptomatic despite H1-antihistamines2-4 ...